BlackRock, Inc. 13D and 13G filings for IDEXX Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 7,599,078 9.400% | -1,455,151 (-16.07%) | Filing |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 9,054,229 10.900% | 551,348 (+6.48%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,502,881 10.300% | 0 (Unchanged) | Filing |
| 2023-01-20 3:00 pm Sale | 2022-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,502,881 10.300% | -487,705 (-5.42%) | Filing |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,990,586 10.600% | 0 (Unchanged) | Filing |
| 2022-01-25 3:03 pm Purchase | 2021-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,990,586 10.600% | 378,181 (+4.39%) | Filing |
| 2021-09-09 4:20 pm Purchase | 2021-08-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 8,612,405 10.100% | 722,813 (+9.16%) | Filing |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | IDEXX Laboratories, Inc. IDXX | BlackRock Inc. BLK | 7,889,592 9.200% | 464,747 (+6.26%) | Filing |